Literature DB >> 8699182

Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa.

W F Chiou1, J F Liao, C F Chen.   

Abstract

The vasoreactivity of dehydroevodiamine (1), evodiamine (2), and rutaecarpine (3), quinazoline alkaloids isolated from Evodia rutaecarpa, to aorta smooth muscle demonstrated that they produce a vasodilatory effect on endothelium-intact rat aorta with equal potency. Compound 3 produced a full (100%) nitric oxide-dependent vasodilatation, whereas 2 and 1 produced a partially endothelium-dependent effect, 50% and 10%, respectively. At the same time, I and 2 may also act by other mechanisms, including probably an alpha1-adrenoceptor blocking action and a 5-HT antagonizing action, respectively.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8699182     DOI: 10.1021/np960161+

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  18 in total

1.  Effect of chirality and lipophilicity in the functional activity of evodiamine and its analogues at TRPV1 channels.

Authors:  Luciano De Petrocellis; Aniello Schiano Moriello; Gabriele Fontana; Alessandro Sacchetti; Daniele Passarella; Giovanni Appendino; Vincenzo Di Marzo
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

2.  Protective effects of calcitonin gene-related peptide-mediated evodiamine on guinea-pig cardiac anaphylaxis.

Authors:  Wei-Qing Rang; Yan-Hua Du; Chang-Ping Hu; Feng Ye; Gui-Shan Tan; Han-Wu Deng; Yuan-Jian Li
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-02-04       Impact factor: 3.000

3.  Rutaecarpine inhibits angiotensin II-induced proliferation in rat vascular smooth muscle cells.

Authors:  Yan-ju Li; Feng Zhang; Qi-hai Gong; Qin Wu; Li-mei Yu; An-sheng Sun
Journal:  Chin J Integr Med       Date:  2013-06-17       Impact factor: 1.978

Review 4.  Pathophysiology and therapeutic possibilities of calcitonin gene-related peptide in hypertension.

Authors:  I Márquez-Rodas; F Longo; R P Rothlin; G Balfagón
Journal:  J Physiol Biochem       Date:  2006-03       Impact factor: 5.080

5.  Anti-inflammatory and anti-infectious effects of Evodia rutaecarpa (Wuzhuyu) and its major bioactive components.

Authors:  Jyh-Fei Liao; Wen-Fei Chiou; Yuh-Chiang Shen; Guei-Jane Wang; Chieh-Fu Chen
Journal:  Chin Med       Date:  2011-02-14       Impact factor: 5.455

6.  Evodiamine Induces Transient Receptor Potential Vanilloid-1-Mediated Protective Autophagy in U87-MG Astrocytes.

Authors:  Ann-Jeng Liu; Sheng-Hao Wang; Sz-Ying Hou; Chien-Ju Lin; Wen-Ta Chiu; Sheng-Huang Hsiao; Thay-Hsiung Chen; Chwen-Ming Shih
Journal:  Evid Based Complement Alternat Med       Date:  2013-12-24       Impact factor: 2.629

7.  Characterization of the in Vitro Metabolic Profile of Evodiamine in Human Liver Microsomes and Hepatocytes by UHPLC-Q Exactive Mass Spectrometer.

Authors:  Zhaowei Zhang; Tianzi Fang; Hongyun Zhou; Jie Yuan; Qingwang Liu
Journal:  Front Pharmacol       Date:  2018-02-22       Impact factor: 5.810

Review 8.  Pharmacological actions of multi-target-directed evodiamine.

Authors:  Hui Yu; Hongwei Jin; Wuzhuang Gong; Zhanli Wang; Huaping Liang
Journal:  Molecules       Date:  2013-01-31       Impact factor: 4.411

9.  Development and validation of an UPLC-ESI-MS/MS method for determination of dehydroevodiamine, limonin, evodiamine, and rutaecarpine in Evodiae Fructus.

Authors:  Yang Zhao; Yunling Zhao; Xin Zhou; Xiaojian Gong
Journal:  Pharmacogn Mag       Date:  2014-07       Impact factor: 1.085

10.  Novel interactomics approach identifies ABCA1 as direct target of evodiamine, which increases macrophage cholesterol efflux.

Authors:  Limei Wang; Pierre Eftekhari; Daniel Schachner; Irena D Ignatova; Veronika Palme; Nicole Schilcher; Angela Ladurner; Elke H Heiss; Herbert Stangl; Verena M Dirsch; Atanas G Atanasov
Journal:  Sci Rep       Date:  2018-07-23       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.